Annis Gardner Whiting Capital Advisors, LLC Biogen Inc. Transaction History
Annis Gardner Whiting Capital Advisors, LLC
- $289 Billion
- Q2 2025
A detailed history of Annis Gardner Whiting Capital Advisors, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Annis Gardner Whiting Capital Advisors, LLC holds 4,809 shares of BIIB stock, worth $620,024. This represents 0.21% of its overall portfolio holdings.
Number of Shares
4,809
Previous 4,413
8.97%
Holding current value
$620,024
Previous $604 Million
0.01%
% of portfolio
0.21%
Previous 0.26%
Shares
7 transactions
Others Institutions Holding BIIB
# of Institutions
1,010Shares Held
126MCall Options Held
2.3MPut Options Held
4.25M-
Vanguard Group Inc Valley Forge, PA17.3MShares$2.23 Billion0.04% of portfolio
-
Primecap Management CO Pasadena, CA15.8MShares$2.04 Billion1.62% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$1.87 Billion0.08% of portfolio
-
State Street Corp Boston, MA7.4MShares$954 Million0.04% of portfolio
-
Wellington Management Group LLP Boston, MA4.67MShares$602 Million0.13% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $18.6B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...